Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2019-06-04Clinical Trial Update: Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma [Phase 2, Phase 3]
A clinical trial comparing systemic chemotherapy to transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma has been wi…
-
CLINICAL_TRIALS withdrawal · 2019-06-04Clinical Trial Update: Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma [Phase 2, Phase 3]
A clinical trial comparing adjuvant transcatheter arterial chemoembolization to adjuvant systemic chemotherapy for hepatocellular carcinoma …
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer [Phase 2]
Phase 2 trial update for sorafenib with micro-therapy guided by Primovist-enhanced MRI in patients with inoperable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein [Phase 3]
Phase 3 trial comparing ramucirumab to placebo in hepatocellular carcinoma with elevated baseline AFP has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Novel Treatment of Advanced Hepatocellular Carcinoma [Phase 3]
Phase 3 clinical trial update for a novel treatment in advanced hepatocellular carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi [Phase 3]
Phase 3 randomized trial evaluating TACE with or without EBRT for hepatocellular carcinoma with portal vein tumor thrombi; status and result…
-
CLINICAL_TRIALS withdrawal · 2019-05-02Clinical Trial Update: Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria [Phase 3]
Phase 3 trial comparing lenvatinib plus PD-1 antibody versus TACE for intermediate-stage hepatocellular carcinoma beyond Up-to-seven criteri…
-
CLINICAL_TRIALS withdrawal · 2019-05-02Clinical Trial Update: Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCC [Phase 3]
A Phase 3 trial comparing lenvatinib plus a PD-1 antibody versus lenvatinib alone for hepatocellular carcinoma has been withdrawn.
-
CLINICAL_TRIALS research · 2019-04-23Clinical Trial Update: Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization [Phase 2]
Phase 2 clinical trial investigating an integrated imaging strategy to phenotype progression of liver tumors during and after chemoembolizat…
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC [Phase 2]
Phase 2 trial comparing sorafenib with hepatic arterial infusion chemotherapy (HAIC) using FOLFOX versus HAIC using oxaliplatin for advanced…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating adjuvant gefitinib (Iressa) for resectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Transarterial Chemoembolization Prior to Transplantation for Hepatocellular Carcinoma [Phase 3]
Phase 3 trial investigating transarterial chemoembolization before transplantation for hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
A clinical trial update reports on the safety and efficacy of donafenib in patients with advanced hepatocellular carcinoma across Phase 1 an…
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update investigating stereotactic body radiation therapy combined with anti-PD-1 antibody in patients with hepatocell…
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion [Phase 4]
Phase 4 trial update on preoperative transarterial chemoembolization for resectable hepatocellular carcinoma with portal vein tumor thrombus…
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC [Phase 3]
Phase 3 trial comparing chemoembolization with or without mixing chemotherapy with Lipiodol for unresectable hepatocellular carcinoma has co…
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma [Phase 3]
Phase 3 trial updating comparison of two solvents used with a chemotherapy agent for transarterial chemoembolization in hepatocellular carci…
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma [Phase 2]
Phase II trial evaluating sorafenib with concurrent hepatic arterial infusion chemotherapy for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib [Phase 3]
Phase 3 study evaluating cabozantinib vs placebo in hepatocellular carcinoma after sorafenib; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L [Phase 3]
Phase 3 placebo-controlled clinical trial update for Hepcortespenlisimut-L in hepatocellular carcinoma (liver cancer).
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating localized concurrent chemoradiation followed by sorafenib sequential therapy in advanced hepatocellular ca…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC) [Phase 2]
This document reports on a Phase 2 clinical trial sponsored by Sun Yat-sen University evaluating the efficacy of combining transarterial che…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: The Efficacy of Transarterial Chemoinfusion (TAI) Combine Toripalimab in Advanced Hepatocellular Carcinoma (HCC) [Phase 2]
A Phase 2 trial investigates the efficacy of Transarterial Chemoinfusion (TAI) combined with toripalimab in advanced hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma [Phase 1]
This clinical trial update reports a Phase 1 study evaluating the safety and efficacy of deferoxamine for unresectable hepatocellular carcin…
-
CLINICAL_TRIALS research · 2019-02-21Clinical Trial Update: Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC
This entry reports an ongoing clinical trial evaluating chemoembolization using LifePearl polyethylene glycol drug-eluting microspheres load…